Schetters, S. T. T., Rodriguez, E., Kruijssen, L. J. W., Crommentuijn, M. H. W., Boon, L., Van den Bossche, J., . . . Van Kooyk, Y. (2020). Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy. J Immunother Cancer.
Chicago Style aipamenaSchetters, Sjoerd T T., Ernesto Rodriguez, Laura J W. Kruijssen, Matheus H W. Crommentuijn, Louis Boon, Jan Van den Bossche, Joke M M. Den Haan, and Yvette Van Kooyk. "Monocyte-derived APCs Are Central to the Response of PD1 Checkpoint Blockade and Provide a Therapeutic Target for Combination Therapy." J Immunother Cancer 2020.
MLA aipamenaSchetters, Sjoerd T T., et al. "Monocyte-derived APCs Are Central to the Response of PD1 Checkpoint Blockade and Provide a Therapeutic Target for Combination Therapy." J Immunother Cancer 2020.